12/01/2019 00:42:16

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of YogaWorks, Inc. - YOGA

NEW YORK, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of YogaWorks, Inc. (“YogaWorks” or the “Company”) (NASDAQ: YOGA).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether YogaWorks and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On or around August 11, 2017, YogaWorks conducted its initial public offering (“IPO”), issuing approximately 7.3 million shares of common stock priced at $5.50 per share.  On August 14, 2018, YogaWorks reported its financial and operating results for the second quarter of 2018 and held a conference call to discuss the results.  YogaWorks announced that it had lowered the midpoint of earnings before interest, taxes, depreciation, and amortization guidance by roughly $2.5 million, citing changes in its promotional activities as well as planned training and brand building initiatives.  During the conference call, YogaWorks further disclosed that the Company would be pivoting from its much-touted acquisition strategy and refocusing on its base business and improving the profitability of its revenue stream.

Following these announcements, YogaWorks’ stock price fell $0.77 per share, or 41.4%, to close at $1.09 per share on August 15, 2018.  Since the IPO, YogaWorks’ stock price has fallen precipitously from its offering price of $5.50 per share.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:

Robert S. Willoughby

Pomerantz LLP

rswilloughby@pomlaw.com

888-476-6529 ext. 9980

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
20 Jun
 
I øjeblikket sidder "vinderne" ved folketingsvalget og forhandler regeringsgrundlag. De er enige om ..
45
20 Jun
 
Måske jeg er den eneste, men savner Alpehue og hans gode indlæg... er han her under et andet alias? ..
23
23 Jun
 
Kære Nets-formand, du er i Danmark, ikke USA Vi er et samfund, hvor få har for meget og færre for li..
21
21 Jun
VELO
Mangel på to tacrolimus - konvertere pat. til Envarsus   I USA konvertere de patienter til Envarsus ..
20
21 Jun
 
@ckt - synes egentlig det havde vaeret bedre, du ikke havde skrevet noget overhovedet..
20
19 Jun
OMXC25
  De vil aldrig få penge nok. Jeg vil tro, at der aldrig er tilført de offentlige kasser flere penge..
20
20 Jun
CHEMM
ChemoMetec opjusterer forventningerne til omsætningen og driftsresultatet som følger af højere forve..
19
25 Jun
VELO
https://m.medwatch.dk/article/11464164
17
21 Jun
VELO
Ser ud til at man omkring 1 juli starter et nyt forsøg op med Envarsus hvor man tilsyneladende forve..
17
25 Jun
VELO
Jeg har lavet denne beregning, min forventning til Q1 ramte kun 9.000 USD ved siden af. Siden har je..
16

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Shareholder Alert: Securities Class Action Lawsuit Filed Against Eros International PLC – EROS – Kehoe Law Firm, P.C. Investigating Claims on Behalf of Eros Investors
2
UPDATE – PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
3
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Anheuser-Busch InBev SA/NV and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
4
AOS INVESTOR DEADLINE REMINDER: Hagens Berman Reminds A.O. Smith (AOS) Investors of Lead Plaintiff Deadline, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm
5
Annual Financial Report and Notice of Annual General Meeting

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 June 2019 23:48:46
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB1 - 2019-06-26 00:48:46 - 2019-06-25 23:48:46 - 1000 - Website: OKAY